RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...

Merck is slashing $3 billion from its annual spending as it braces for off-brand competition to its cancer drug Keytruda, the best-selling medicine in the world. The drugmaker will cut administrative, ...

Matthew Herper covers medical innovation — both its promise and its perils. Merck said a new formulation of the best-selling drug, Keytruda, appears to deliver similar blood levels of the medicine ...

While increasing collaboration between payers and providers was a major theme at HIMSS in Orlando last week, one other major stakeholder has been quite a bit harder to find in conversations about big ...

Merck (MRK) ended the recent trading session at $111.01, demonstrating a +2.54% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.53%.

Michael Rosenblatt, dean of Tufts University School of Medicine (TUSM), yesterday morning announced his decision to step down effective Dec. 20. He will take up the newly created position of chief ...

Bayer AG’s proposed purchase of Merck & Co.’s consumer health unit would create a combined over-the-counter business with many of the products in a typical medicine chest. Sales in 2013 for the top ...

Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to ...